Kovack Advisors, Inc. Organicell Regenerative Medicine, Inc. Transaction History

Kovack Advisors, Inc.

  • $919 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 22, 2023
BUY
$0.01 - $0.05 $2,500 - $12,500
250,000 New
250,000 $5,000

About Organicell Regenerative Medicine, Inc.

OCEL Quotes by TradingView
  • Ticker OCEL
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,476,130,048
  • Market Cap $1.7B
  • Description
  • Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs...
More about OCEL
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email